JP2012526852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526852A5 JP2012526852A5 JP2012511052A JP2012511052A JP2012526852A5 JP 2012526852 A5 JP2012526852 A5 JP 2012526852A5 JP 2012511052 A JP2012511052 A JP 2012511052A JP 2012511052 A JP2012511052 A JP 2012511052A JP 2012526852 A5 JP2012526852 A5 JP 2012526852A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- genotype
- promoter gene
- agent
- result
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21621609P | 2009-05-14 | 2009-05-14 | |
| US61/216,216 | 2009-05-14 | ||
| US21768209P | 2009-06-03 | 2009-06-03 | |
| US21767909P | 2009-06-03 | 2009-06-03 | |
| US61/217,679 | 2009-06-03 | ||
| US61/217,682 | 2009-06-03 | ||
| PCT/US2010/034974 WO2010132817A1 (en) | 2009-05-14 | 2010-05-14 | Carcinoma diagnosis and treatments, based on odc1 genotype |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015213116A Division JP2016074672A (ja) | 2009-05-14 | 2015-10-29 | Ｏｄｃ１の遺伝子型に基づく癌腫診断及び治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526852A JP2012526852A (ja) | 2012-11-01 |
| JP2012526852A5 true JP2012526852A5 (cg-RX-API-DMAC10.html) | 2013-06-27 |
| JP6083860B2 JP6083860B2 (ja) | 2017-02-22 |
Family
ID=43085356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511052A Expired - Fee Related JP6083860B2 (ja) | 2009-05-14 | 2010-05-14 | Ｏｄｃ１の遺伝子型に基づく癌腫診断及び治療 |
| JP2015213116A Pending JP2016074672A (ja) | 2009-05-14 | 2015-10-29 | Ｏｄｃ１の遺伝子型に基づく癌腫診断及び治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015213116A Pending JP2016074672A (ja) | 2009-05-14 | 2015-10-29 | Ｏｄｃ１の遺伝子型に基づく癌腫診断及び治療 |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2430452T3 (da) | 2009-05-14 | 2014-10-06 | Univ Arizona State | Carcinom-diagnose og behandlinger, baseret på odc1-genotype |
| EP2568978B1 (en) * | 2010-05-14 | 2019-04-24 | Arizona Board of Regents on Behalf of University of Arizona | Cancer prevention and treatment based on dietary polyamine content |
| US20120172244A1 (en) | 2010-12-20 | 2012-07-05 | Steven Buechler | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease |
| EP2655663A4 (en) * | 2010-12-20 | 2015-01-28 | Univ Notre Dame Du Lac | BIOMARKERS AND THEIR USE FOR PROGNOSIS AND TREATMENT STRATEGIES FOR RIGHT-SIDED AND LEFT-SIDE COLON CARCINOMA |
| EP2912193B1 (en) | 2012-10-29 | 2018-08-29 | Arizona Board of Regents on Behalf of University of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
| CA2952771A1 (en) * | 2014-06-18 | 2015-12-23 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Carcinoma diagnosis and treatment based on odc1 genotype |
| JP2018507910A (ja) * | 2015-02-12 | 2018-03-22 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ジ・ユニバーシティ・オブ・アリゾナ | 神経芽細胞腫を治療する方法 |
| CA3227242A1 (en) * | 2015-03-16 | 2016-09-22 | Personal Genome Diagnostics Inc. | Systems and methods for analyzing nucleic acid |
| WO2017075576A1 (en) | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| JP2018536707A (ja) | 2015-10-30 | 2018-12-13 | キャンサー プリベンション ファーマシューティカルズ，インコーポレイテッド | エフロルニチンとスリンダクの固定用量複合製剤 |
| JP6963271B2 (ja) * | 2017-01-20 | 2021-11-05 | 国立大学法人東海国立大学機構 | イヌの遺伝性消化管腫瘍症の遺伝子診断法 |
| TWI917322B (zh) | 2019-05-17 | 2026-03-11 | 美商癌症預防製藥股份有限公司 | 治療家族性腺瘤性瘜肉症之方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3654349A (en) | 1970-05-01 | 1972-04-04 | Merck & Co Inc | Substituted indenyl acetic acids |
| US3647858A (en) | 1970-05-01 | 1972-03-07 | Merck & Co Inc | Process for preparing 1-benzylidene-3-indenyl acetic acids |
| US4413141A (en) | 1977-07-11 | 1983-11-01 | Merrell Toraude Et Compagnie | 2-(Difluoromethyl)-2,5-diaminopentanoic acid |
| US4330559A (en) * | 1977-07-11 | 1982-05-18 | Merrell-Toraude Et Cie | Method of treating benign prostatic hypertrophy |
| BR8108820A (pt) | 1980-09-24 | 1982-08-24 | Cetus Corp | Processo e sonda de diagnostico |
| EP0084796B1 (en) | 1982-01-22 | 1990-05-02 | Cetus Corporation | Hla typing method and cdna probes used therein |
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4683194A (en) | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4859452A (en) | 1986-01-17 | 1989-08-22 | Board Of Regents, The University Of Texas System | Methods for the reduction of difluoromethylornithine associated toxicity |
| CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
| US4925835A (en) | 1986-05-01 | 1990-05-15 | Sloan-Kettering Institute For Cancer Research | Aziridinyl putrescine containing compositions and their uses in treating prostate cancer |
| US5002879A (en) | 1986-05-06 | 1991-03-26 | Merrell Dow Pharmaceuticals | Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor |
| CA1338457C (en) | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| FR2706255B1 (fr) | 1993-06-17 | 1995-10-27 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques. |
| WO1995021271A1 (en) | 1994-02-07 | 1995-08-10 | Molecular Tool, Inc. | Ligase/polymerase-mediated genetic bit analysistm of single nucleotide polymorphisms and its use in genetic analysis |
| US5843929A (en) * | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
| EP1067919A1 (en) * | 1998-03-28 | 2001-01-17 | THE ARIZONA BOARD OF REGENTS on behalf of THE UNIVERSITY OF ARIZONA | Dfmo and sulindac combination in cancer chemoprevention |
| US7700568B2 (en) * | 1998-06-30 | 2010-04-20 | Sloan-Kettering Institute For Cancer Research | Uses of DNA-PK |
| WO2000038715A2 (en) * | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Use of an integrin antagonist and radiation in the treatment of neoplasia |
| US6753422B2 (en) | 1999-03-01 | 2004-06-22 | O'brien Thomas G. | Odc allelic analysis method for assessing carcinogenic susceptibility |
| CA2373931A1 (en) | 1999-05-17 | 2000-11-23 | Richard Love | Dfmo and celecoxib in combination for cancer chemoprevention and therapy |
| US6602910B2 (en) | 2000-03-07 | 2003-08-05 | Ilex Oncology, Inc. | D-enantiomer of DFMO and methods of use therefor |
| WO2001068076A2 (en) | 2000-03-07 | 2001-09-20 | Ilex Oncology, Inc. | D-enantiomer of dfmo and methods of use thereof for treating cancer |
| AU2001285232A1 (en) | 2000-08-24 | 2002-03-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Alpha-difluoromethylornithine (dfmo) use in the human prostate |
| AU2002343609B2 (en) | 2001-11-16 | 2008-12-11 | Als Therapy Development Foundation, Inc. | Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
| WO2007075673A1 (en) | 2005-12-20 | 2007-07-05 | University Of Hawaii | Treatment regimen for n-myc, c-myc, and l-myc amplified and overexpressed tumors |
| US8283331B2 (en) | 2007-10-09 | 2012-10-09 | Children's Medical Center Corporation | Methods to regulate miRNA processing by targeting Lin-28 |
| MX2011005731A (es) | 2008-12-08 | 2011-06-21 | Procter & Gamble | Composicion para el ciudado personal en la forma de un articulo que tiene un recubrimiento hidrofobo residente en la superficie. |
| DK2430452T3 (da) | 2009-05-14 | 2014-10-06 | Univ Arizona State | Carcinom-diagnose og behandlinger, baseret på odc1-genotype |
| EP2568978B1 (en) | 2010-05-14 | 2019-04-24 | Arizona Board of Regents on Behalf of University of Arizona | Cancer prevention and treatment based on dietary polyamine content |
| EP2912193B1 (en) | 2012-10-29 | 2018-08-29 | Arizona Board of Regents on Behalf of University of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
-
2010
- 2010-05-14 DK DK10775626.4T patent/DK2430452T3/da active
- 2010-05-14 US US12/780,592 patent/US8329636B2/en active Active
- 2010-05-14 WO PCT/US2010/034974 patent/WO2010132817A1/en not_active Ceased
- 2010-05-14 CA CA2761946A patent/CA2761946A1/en not_active Abandoned
- 2010-05-14 SI SI201030738T patent/SI2430452T1/sl unknown
- 2010-05-14 PT PT107756264T patent/PT2430452E/pt unknown
- 2010-05-14 AU AU2010248803A patent/AU2010248803B2/en not_active Ceased
- 2010-05-14 CN CN201080031983.5A patent/CN102483415B/zh not_active Expired - Fee Related
- 2010-05-14 HR HRP20140887AT patent/HRP20140887T1/hr unknown
- 2010-05-14 EP EP10775626.4A patent/EP2430452B1/en active Active
- 2010-05-14 PL PL10775626T patent/PL2430452T3/pl unknown
- 2010-05-14 ES ES10775626.4T patent/ES2507145T3/es active Active
- 2010-05-14 JP JP2012511052A patent/JP6083860B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-14 IL IL216369A patent/IL216369B/en active IP Right Grant
-
2012
- 2012-12-10 US US13/709,753 patent/US9121852B2/en active Active
-
2014
- 2014-11-21 SM SM201400177T patent/SMT201400177B/xx unknown
-
2015
- 2015-09-01 US US14/841,750 patent/US9937141B2/en active Active
- 2015-10-29 JP JP2015213116A patent/JP2016074672A/ja active Pending
-
2018
- 2018-02-23 US US15/904,153 patent/US20190038584A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tan et al. | Optimizing pain management to facilitate enhanced recovery after surgery pathways | |
| Sim et al. | Prospective randomized, double‐blind, placebo‐controlled study of pre‐and postoperative administration of a COX‐2‐specific inhibitor as opioid‐sparing analgesia in major colorectal surgery | |
| van der Heijde et al. | Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty‐two–week, randomized, controlled study | |
| Pogatzki-Zahn et al. | Nonopioid analgesics for postoperative pain management | |
| Mercadante et al. | Pharmacological management of cancer pain in the elderly | |
| Joffe et al. | Evaluation and treatment of pain in critically ill adults | |
| Viscusi et al. | Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability | |
| Senek et al. | Continuous drug delivery in Parkinson’s disease | |
| CY1110495T1 (el) | Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα | |
| Lotia et al. | New and emerging medical therapies in Parkinson’s disease | |
| Minkowitz et al. | Sufentanil sublingual tablet 30 mcg for the management of pain following abdominal surgery: A randomized, placebo‐controlled, phase‐3 study | |
| Stasiowska et al. | Postoperative pain management | |
| JP2009531451A (ja) | 低投与量の非ステロイド系抗炎症薬及びβ−シクロデキストリンの配合物 | |
| JP2018507910A5 (cg-RX-API-DMAC10.html) | ||
| Bhaskar et al. | Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| HRP20140887T1 (hr) | Dijagnoza karcinoma i lijeäśenje, koje se temelji na odc1 genotipu | |
| Douzjian et al. | Old drug, new route: a systematic review of intravenous acetaminophen after adult cardiac surgery | |
| TW201043225A (en) | Antitumour combination comprising AVE8062 and sorafenib | |
| Al Dakheel et al. | Emerging drugs for levodopa-induced dyskinesia | |
| Aguado et al. | The effects of gabapentin on acute opioid tolerance to remifentanil under sevoflurane anesthesia in rats | |
| Chung et al. | Long‐term follow‐up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension | |
| WO2015191473A9 (en) | Fixed dose combination for pain relief without edema | |
| MA31227B1 (fr) | Composition pharmaceutique renfermant du phloroglucinol et du paracetamol. |